<DOC>
	<DOCNO>NCT03101722</DOCNO>
	<brief_summary>To investigate effect hear aid , huperzine A combination hearing aid huperzine A tinnitus suppression , hear cognitive function protection patient presbycusis</brief_summary>
	<brief_title>Effects Hearing Rehabilitative Interventions Huperzine A Presbycusis ( Δ , kHz , dB , MMSE , AD )</brief_title>
	<detailed_description>To continuously recruit 150 patient presbycusis tinnitus 400 patient presbycusis hospital Fudan university .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Presbycusis</mesh_term>
	<mesh_term>Huperzine A</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>1. mild moderate/severe hear impairment ( pure tone average across octave frequency 0.25 4 kHz 2679 dB HL ) without tinnitus ; 2. tinnitus exist 3+ month ; 3 . Han Chinese patient ; 4. age 60 year . 1. air bone gap average across 0.5 , 1 2 kHz ≤ 15 dB HL well hear ear ; 2. first language chinese ; 3. dependence due poor physical activity ; 4. acute brain trauma stroke within 2 week ; 5. psychiatric disorder ; 6. vision impairment ; 7. normal hear hear impairment 80 dB HL .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>presbycusis</keyword>
	<keyword>tinnitus</keyword>
	<keyword>cognitive impairment</keyword>
	<keyword>Huperzine A</keyword>
	<keyword>hearing aid</keyword>
	<keyword>age-related hearing impairment</keyword>
</DOC>